Authors: Konovalova N., Molodaya A., Dolenko L., Kovtun A., Yurchenko L., Rybalko A., The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine, Odessa, Ukraine
Frequency of bacterial conjunctivitis and antibacterial activity of drugs in their treatment. Bacterial conjunctivitis is the cause of frequent referral to an ophthalmologist. They are characterized by seasonality, sharpness of the current, decrease and loss of working capacity and high invasiveness. The urgency of the problem is due to the growing resistance to antibacterial drugs in ophthalmic practice.
To analyze the frequency of occurrence, antibiotic resistance antibacterial activity of drugs in the treatment of bacterial conjunctivitis on the basis of data analysis for 2019.
Material and methods
The analysis of 346 (692 eyes) bacteriological studies of biological material in order to study the etiological factors of inflammatory diseases of the eyes, to assess the state of sensitivity of microorganisms to modern antibiotics.
Results and discussion
A study we conducted in 2019 showed Gram-positive flora in 97.3% of patients. Fungal flora – in 3 patients (0.86%). Allocation of gram-negative flora – 4 people (1.1%). It is established that the most effective antibacterial drugs are: Levoxymed (for epidermal, Staphylococcus aureus, Escherichia coli, streptococcal infection, moracella), Medetrom (for hemolytic staphylococcus) and Floximed (for enterococci).
- In the study of bacterial flora, epidermal staphylococcus (63.5%) is most commonly detected, golden staphylococcus (11.8%), then hemolytic (5.7%), the most effective drugs for topical use in ophthalmology at present. time turned out to be a group of drugs – eye drops of Levoxymed, Floximed, Medetrom.
- The study we conducted in 2019 showed that the most effective among them are: Levoxymed (for epidermal, Staphylococcus aureus, Escherichia coli, streptococcal infection, moroccelles), Medetrom (for hemolytic staphylococcus) and Floximed (for enterox).
Keywords: bacterial flora, resistance, Levoksimed, Phloximed, Medetrom.